Rossari Biotech Limited (NSE:ROSSARI)
India
· Delayed Price · Currency is INR 713.95
+5.40 (0.76%)
May 16, 2025, 3:29 PM IST
Rossari Biotech Revenue
In the fiscal year ending March 31, 2025, Rossari Biotech had annual revenue of 20.80B INR with 13.64% growth. Rossari Biotech had revenue of 5.80B in the quarter ending March 31, 2025, with 22.60% growth.
Revenue
20.80B
Revenue Growth
+13.64%
P/S Ratio
1.90
Revenue / Employee
46.23M
Employees
450
Market Cap
39.50B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UltraTech Cement | 759.55B |
| Asian Paints | 339.06B |
| Grasim Industries | 1,399.44B |
| Vedanta | 1,507.25B |
| Pidilite Industries | 131.40B |
| Solar Industries India | 69.84B |
| Shree Cement | 192.83B |
| Jindal Steel & Power | 497.65B |
Rossari Biotech News
- 3 months ago - Rossari Biotech’s subsidiary wins GST appeal; previous tax order set aside - Business Upturn
- 4 months ago - Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and ... - GuruFocus
- 4 months ago - Q3 2025 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Rossari Biotech stock drops 4.28% following Q2 results - Business Upturn